Navigation Links
New Director of Bioanalytical Services Joins Toxikon

BEDFORD, Mass., Jan. 13 /PRNewswire/ -- Toxikon, a successful, 30-year old preclinical research organization with highly diversified capabilities headquartered in the Greater Boston area, announces that Joseph Pav, Ph.D. has joined the firm to direct the continued growth of the preclinical and clinical bioanalytical services unit. Dr. Pav brings a wealth of knowledge and experience to the organization from his prior roles in method development, validation, analysis, and automation.  His prior experience included senior scientific and management roles at Purdue Frederick, Boehringer Ingelheim, Wyeth Research, and PPDI.

Toxikon Corporation, with facilities in the US and Belgium, is ISO/IEC 17025 accredited and registered with the U.S. FDA and Japanese MHLW.  The company performs in vivo, analytical, and in vitro testing for the pharmaceutical, biotechnology, and medical device sectors. Services include toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical,  microbiology, and full in vitro toxicology and immunology services.  The company has over 1,000 clients in 20 countries worldwide.  

SOURCE Toxikon Corporation



SOURCE Toxikon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
2. PharmAthene Appoints Jeffrey W. Runge, M.D. to the Companys Board of Directors
3. China Sky Medical, Inc. Has 30 Medicines that will Be Included in Chinas National Insurance Directory
4. Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
5. Dennis Winger Joins Nektar Therapeutics Board of Directors
6. Endologix Appoints Dan Lemaitre to its Board of Directors
7. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
8. Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
9. Vivakor Announces Additions to Board of Directors and Scientific Advisory Board
10. Cytochroma Announces Appointment of Peter Moldt to Board of Directors
11. Richard T. Crowder Joins Neogens Board of Directors
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):